Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to $166.0 million.

  • Nutex Health's Cash & Equivalents rose 25397.69% to $166.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $166.0 million, marking a year-over-year increase of 25397.69%. This contributed to the annual value of $40.6 million for FY2024, which is 8471.0% up from last year.
  • Nutex Health's Cash & Equivalents amounted to $166.0 million in Q3 2025, which was up 25397.69% from $96.7 million recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Cash & Equivalents registered a high of $166.0 million during Q3 2025, and its lowest value of $3.7 million during Q1 2021.
  • For the 5-year period, Nutex Health's Cash & Equivalents averaged around $42.2 million, with its median value being $34.3 million (2022).
  • As far as peak fluctuations go, Nutex Health's Cash & Equivalents skyrocketed by 13401415.84% in 2021, and later crashed by 3577.03% in 2023.
  • Over the past 5 years, Nutex Health's Cash & Equivalents (Quarter) stood at $36.1 million in 2021, then decreased by 5.16% to $34.3 million in 2022, then crashed by 35.77% to $22.0 million in 2023, then skyrocketed by 84.71% to $40.6 million in 2024, then skyrocketed by 308.58% to $166.0 million in 2025.
  • Its last three reported values are $166.0 million in Q3 2025, $96.7 million for Q2 2025, and $84.7 million during Q1 2025.